Use of Model for End-Stage Liver Disease Exceptions for Donation After Cardiac Death Graft Recipients Relisted for Liver Transplantation

被引:8
作者
Maduka, Richard C. [1 ]
Abt, Peter L. [2 ]
Goldberg, David S. [3 ,4 ,5 ]
机构
[1] Hosp Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Dept Surg, Div Transplantat, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[5] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
关键词
SURVIVAL; RETRANSPLANT; ALLOGRAFTS; MELD;
D O I
10.1002/lt.24079
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Donation after cardiac death (DCD) liver transplantation is associated with increased biliary complications and graft failure. Yet for unclear reasons, DCD recipients relisted for transplantation have lower wait-list mortality than other retransplant candidates. We used Organ Procurement and Transplantation Network and United Network for Organ Sharing data from 2002 to 2011 to evaluate all DCD recipients relisted for transplantation to evaluate the impact of the utilization of Model for End-Stage Liver Disease (MELD) exception points on wait-list outcomes. Of 262 DCD recipients relisted for liver transplantation >2 weeks after initial transplantation, 82 (31.3%) applied for a nonstandardized MELD exception, and 68 (82.9%) had 1 exception approved. Of the relisted DCD recipients, 187 (71.4%) underwent retransplantation; among those with an approved MELD exception, 85.2% underwent retransplantation versus 57.1% of those with an exception denied and 69.4% of those not applying for an exception (P=0.02). In contrast, those receiving MELD exception points were significantly less likely to be removed from the wait list for death or clinical deterioration in comparison with those not applying for an exception (7.1% versus 19.4%, P=0.02). In multivariate models, patients with an approved exception were 3.3 times more likely to undergo retransplantation than those not applying for an exception. Standardized criteria for exception points among DCD recipients should be established to ensure uniform access to retransplantation. Liver Transpl 21:554-560, 2015. (c) 2015 AASLD.
引用
收藏
页码:554 / 560
页数:7
相关论文
共 13 条
[1]   Survival following liver transplantation from non-heart-beating donors [J].
Abt, PL ;
Desai, NM ;
Crawford, MD ;
Forman, LM ;
Markmann, JW ;
Olthoff, KM ;
Markmann, JF .
ANNALS OF SURGERY, 2004, 239 (01) :87-92
[2]   Survival of Recipients of Livers From Donation After Circulatory Death Who Are Relisted and Undergo Retransplant for Graft Failure [J].
Allen, A. M. ;
Kim, W. R. ;
Xiong, H. ;
Liu, J. ;
Stock, P. G. ;
Lake, J. R. ;
Chinnakotla, S. ;
Snyder, J. J. ;
Israni, A. K. ;
Kasiske, B. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (05) :1120-1128
[3]   Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula [J].
Freeman, Richard B., Jr. ;
Gish, Robert G. ;
Harper, Ann ;
Davis, Gary L. ;
Vierling, John ;
Lieblein, Leslie ;
Klintmalm, Goran ;
Blazek, Jamie ;
Hunter, Robert ;
Punch, Jeffrey .
LIVER TRANSPLANTATION, 2006, 12 (12) :S128-S136
[4]   Lack of Standardization in Exception Points for Patients With Primary Sclerosing Cholangitis and Bacterial Cholangitis [J].
Goldberg, D. ;
Bittermann, T. ;
Makar, G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (06) :1603-1609
[5]   Center Variation in the Use of Nonstandardized Model for End-Stage Liver Disease Exception Points [J].
Goldberg, David S. ;
Makar, George ;
Bittermann, Therese ;
French, Benjamin .
LIVER TRANSPLANTATION, 2013, 19 (12) :1330-1342
[6]   Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis [J].
Goldberg, David S. ;
Camp, Amanda ;
Martinez-Camacho, Alvaro ;
Forman, Lisa ;
Fortune, Brett ;
Reddy, K. Rajender .
LIVER TRANSPLANTATION, 2013, 19 (03) :250-258
[7]   Impact of MELD on Waitlist Outcome of Retransplant Candidates [J].
Kim, H. J. ;
Larson, J. J. ;
Lim, Y. S. ;
Kim, W. R. ;
Pedersen, R. A. ;
Therneau, T. M. ;
Rosen, C. B. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (12) :2652-2657
[8]   A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts [J].
Malinchoc, M ;
Kamath, PS ;
Gordon, FD ;
Peine, CJ ;
Rank, J ;
ter Borg, PCJ .
HEPATOLOGY, 2000, 31 (04) :864-871
[9]  
Olthoff K., 2014, OPTN UNOS LIVER INTE
[10]   Current status of donation after cardiac death liver transplantation [J].
Reich, David J. ;
Hong, Johnny C. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (03) :316-321